"10.1371_journal.ppat.1004639","plos pathogens","2015-02-03T00:00:00Z","Jeong Joo Kim; Christian Flueck; Eugen Franz; Eduardo Sanabria-Figueroa; Eloise Thompson; Robin Lorenz; Daniela Bertinetti; David A Baker; Friedrich W Herberg; Choel Kim","Department of Pharmacology, Baylor College of Medicine, Houston, Texas, United States of America; Department of Biochemistry, University of Kassel, Kassel, Hesse, Germany; Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom; Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States of America","Conceived and designed the experiments: JJK CK. Performed the experiments: JJK CF EF ESF ET. Analyzed the data: JJK CF EF RL DB DAB FWH CK. Contributed reagents/materials/analysis tools: DAB FWH CK. Wrote the paper: JJK CF DAB CK. Designed the constructs for crystallization and purification protocols: JJK. Identified and optimized crystallization conditions: JJK ESF. Solved the structures and refined the crystallographic models: JJK. Built and purified mutant proteins: JJK EF ESF. Generated the KD/EC50 measurements using fluorescence polarization: JJK EF. Designed activation assay and measured activation constants: EF RL DB FWH. Generated transgenic lines of malaria parasite and performed in vivo experiments: CF ET DAB.","The authors have declared that no competing interests exist. The authors also have no affiliation or competing interest with the Eli Lilly company. Eli Lilly has no role in designing and conducting this study. This does not alter our adherence to all PLOS Pathogens policies on sharing data and materials.","2015","02","Jeong Joo Kim","JJK",10,FALSE,2,5,8,4,TRUE,TRUE,FALSE,0,NA,FALSE
